Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Medtronic
Colorcon
Merck

Last Updated: December 7, 2021

Volunteer for clinical trials for CARBIDOPA AND LEVODOPA at ClinicalTrialExchange

DrugPatentWatch Database Preview

CARBIDOPA AND LEVODOPA Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Carbidopa And Levodopa, and when can generic versions of Carbidopa And Levodopa launch?

Carbidopa And Levodopa is a drug marketed by Accord Hlthcare, Alembic Pharms Ltd, Apotex, Impax Labs, Kv Pharm, Mylan, Sciegen Pharms Inc, Sun Pharm Inds, Sun Pharm, Actavis Elizabeth, Ani Pharms, Apotex Inc, Mayne Pharma, SCS, and Watson Labs. and is included in twenty-four NDAs.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Carbidopa And Levodopa

A generic version of CARBIDOPA AND LEVODOPA was approved as carbidopa; levodopa by MAYNE PHARMA on August 28th, 1992.

  Try it Free

Drug patent expirations by year for CARBIDOPA AND LEVODOPA
Drug Prices for CARBIDOPA AND LEVODOPA

See drug prices for CARBIDOPA AND LEVODOPA

Recent Clinical Trials for CARBIDOPA AND LEVODOPA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VistaGen Therapeutics, Inc.Phase 2
BioVie Inc.Phase 1/Phase 2
Northwestern Medical GroupPhase 2

See all CARBIDOPA AND LEVODOPA clinical trials

Pharmacology for CARBIDOPA AND LEVODOPA
Anatomical Therapeutic Chemical (ATC) Classes for CARBIDOPA AND LEVODOPA

US Patents and Regulatory Information for CARBIDOPA AND LEVODOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 214092-002 May 7, 2021 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Apotex Inc CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 077120-002 Jun 2, 2008 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073381-001 Sep 28, 1993 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Scs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074080-003 Mar 25, 1994 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073382-001 Sep 28, 1993 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
Dow
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.